CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Impact assessment of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based correction of semi-quantitative and volume-based PET metrics
DOI 10.1055/a-2777-2278
Bibliografische Angaben
Nachweis in CareLit
Autor:innenAleksei Leontev, Angelina Lokhova, Aleksandr Khalimon, Malika Khodzhibekova, Tatyana Lazutina, Gulnara Khamadeeva, Daria Khodakova, Irina Pylova, Vitaly Bobrov, Leila Atakishieva, Natalia Kadymova, Anastasia Nikiforuk, Bogdan Shvets, Nadezhda Volchenko, Viktoriya Surkova, Petr Shatalov, Andrey Kapr…
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe03/2026
Jahrgang / SeitenJg. 65 · S. 199-206
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Aim The aim of this study was to assess the impact of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based (RC-based) correction of semi-quantitative and volume-based PET metrics. Methods A retrospective multi-center study included 63 patients diagnosed with lung adenocarcinoma who underwent [18F]FDG PET/CT. Acquisition was performed a…
Zitieren
Zitierempfehlung
Aleksei Leontev, Angelina Lokhova, Aleksandr Khalimon, Malika Khodzhibekova, Tatyana Lazutina, Gulnara Khamadeeva, Daria Khodakova, Irina Pylova, Vitaly Bobrov, Leila Atakishieva, Natalia Kadymova, Anastasia Nikiforuk, Bogdan Shvets, Nadezhda Volchenko, Vikto… (2026) Impact assessment of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based correction of semi-quantitative and volume-based PET metrics. Nuklearmedizin - NuclearMedicine, 65 (03), 199-206. https://doi.org/10.1055/a-2777-2278
Mit CareLit weiterarbeiten